EUVIMEDEUVIMED entdecken
Crossref

Screening of new morpholine dithiocarbamate derivatives bearing benzimidazole moiety for anticholinesterase potential

Halide Edip Temel, Gülşen Akalın Çiftçi, Leyla Yurttaş

European Journal of Life Sciences · 2023

DOI: 10.55971/ejls.1328405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Life Sciences, 2023. Verfasst von Halide Edip Temel und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is basically associated with disturbances of cholinesterase metabolism which result in acetylcholine deficiency. Target of acetylcholinesterase (AChE) inhibitors used in symptomatic therapy of disease is to increase of ACh levels. Consequently, cholinesterase inhibitors were developed to increase acetylcholine is to inhibit AChE and butrylcholinesterase (BuChE). Studies demonstrate the clinical importance of dual inhibitors that inhibit not only the acetylcholinesterase enzyme but also the butyrylcholinesterase enzyme. In recent years, benzimidazoles have attracted particular interest owing to their anticolinesterase activity. In this manner, we have synthesized benzimidazole and morpholine including compounds (2a-i). Final compounds were achieved with the reaction of (benzimidazol-2-yl) methyl morpholine-4-carbodithioate and α-bromoacetophenone derivatives in acetone at room temperature with stirring. Inhibition effects of novel morpholine dithiocarbamates (2a-i) were tested on AChE and BuChE. Compound 2d demonstrated dual inhibitory activity on AChE and BuChE (78±1,56, 70,71±1,53, respectively), with the lowest cytotoxicity to normal cell line.

Zitieren

APA

Temel, H. E., Çiftçi, G. A., & Yurttaş, L. (2023). Screening of new morpholine dithiocarbamate derivatives bearing benzimidazole moiety for anticholinesterase potential. European Journal of Life Sciences. https://doi.org/10.55971/ejls.1328405

Vancouver

Temel HE, Çiftçi GA, Yurttaş L. Screening of new morpholine dithiocarbamate derivatives bearing benzimidazole moiety for anticholinesterase potential. European Journal of Life Sciences. 2023. doi:10.55971/ejls.1328405

BibTeX
@article{Temel2023,
  author = {Temel, Halide Edip and Çiftçi, Gülşen Akalın and Yurttaş, Leyla},
  title = {Screening of new morpholine dithiocarbamate derivatives bearing benzimidazole moiety for anticholinesterase potential},
  journal = {European Journal of Life Sciences},
  year = {2023},
  doi = {10.55971/ejls.1328405}
}
Kostenlos starten →